Covid spring booster programme 2025

18 December 2024

Everyone who has Down’s syndrome aged over 6 months old was eligible for a COVID vaccine booster in the Autumn of 2024.

The Joint Committee on Vaccination and Immunisation (JCVI) have recently announced their recommendation for spring Covid boosters, which will be available between April and June of 2025.

The majority of people who have Down’s syndrome will not require a spring booster, as the coverage from their autumn booster is sufficient.

A small proportion of people who have Down’s syndrome, who in addition to having Down’s syndrome, have another health condition or are receiving treatments or medications that would designate them as being immunosuppressed.

Immunosuppression affects individuals undergoing chemotherapy, people who have had a solid organ transplant, bone marrow or stem cell transplant recipients, people who have a HIV infection, multiple myeloma or genetic disorders affecting the immune system (e.g. IRAK-4, NEMO, complement disorder, SCID). Individuals who are receiving immunosuppressive or immunomodulating biological therapy including: anti-TNF, alemtuzumab, ofatumumab, rituximab, patients receiving protein kinase inhibitors or PARP inhibitors, and individuals treated with steroid sparing agents such as cyclophosphamide and mycophenolate mofetil. Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg or more per day for adults. Anyone with a history of haematological malignancy, including leukaemia, lymphoma, and myeloma. Those who require long term immunosuppressive treatment for conditions including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, scleroderma and psoriasis.

Immunosuppressed individuals will be invited to receive a COVID vaccine booster next year, between April and June.

This recommendation follows advice given in the last number of years and so the families of those people that are affected should be aware of their eligibility. Operational details of the programme will be confirmed by the NHS in the new year and so we cannot say exactly how people will be contacted or how they can book, but it is likely this will follow the pattern of previous years.

If anyone would like to discuss this issue, or any issue relating to immunisation/vaccinations and what recommendations exist for children and adults who have Down’s syndrome, contact our Helpline on 0333 1212 300 between 10am and 4pm Monday to Friday or email info@downs-syndrome.org.uk.